Vulnerability Description
Atropim 1.5.26 is vulnerable to Directory Traversal.
CVSS Score
7.5
HIGH
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Atrocore | Atropim | 1.5.26 |
Related Weaknesses (CWE)
References
- https://github.com/nu11secur1ty/CVE-nu11secur1ty/tree/main/vendors/atrocore/atroExploitThird Party Advisory
- https://github.com/nu11secur1ty/CVE-nu11secur1ty/tree/main/vendors/atrocore/atroExploitThird Party Advisory
FAQ
What is CVE-2023-26969?
CVE-2023-26969 is a vulnerability with a CVSS score of 7.5 (HIGH). Atropim 1.5.26 is vulnerable to Directory Traversal.
How severe is CVE-2023-26969?
CVE-2023-26969 has been rated HIGH with a CVSS base score of 7.5/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2023-26969?
Check the references section above for vendor advisories and patch information. Affected products include: Atrocore Atropim.